EP17.15: Evaluation of clinical and biophysical markers as a screening test for late‐onset pre‐eclampsia between 35 and 38 weeks of gestation

Documenti analoghi

• EP17.38: Dietary intake in early‐ and late‐onset pre‐eclampsia
  di: M. Mutmainah, et al.
  Pubblicazione: (2024)
• Placental growth factor for pre‐eclampsia screening before 11 weeks' gestation
  di: R. López‐Mármol, et al.
  Pubblicazione: (2026)
• EP17.13: CVRI as a quick method to estimate peripheral vascular resistance at 13–16 weeks of gestation in patients at high risk of pre‐eclampsia
  di: A. Sepúlveda‐Martínez, et al.
  Pubblicazione: (2024)
• Screening for pre‐eclampsia by maternal serum glycosylated fibronectin and angiogenic markers at 36 weeks' gestation
  di: N. Sokratous, et al.
  Pubblicazione: (2024)
• EP17.07: Comparison of different methods of screening for preterm pre‐eclampsia
  di: D.C. Gómez, et al.
  Pubblicazione: (2024)